Ziopharm Oncology
ZIOP
#8611
Rank
NZ$0.31 B
Marketcap
NZ$1.45
Share price
-0.88%
Change (1 day)
-75.84%
Change (1 year)

Earnings for Ziopharm Oncology (ZIOP)

Earnings in 2021 (TTM): -NZ$0.13 Billion

According to Ziopharm Oncology's latest financial reports the company's current earnings are NZ$3.73 Million. In 2020 the company made an earning of -NZ$0.14 Billion a decrease over its 2019 earnings that were of -NZ$96.69 Million.

Earnings history for Ziopharm Oncology from 2001 to 2021

Annual earnings

Year Earnings Change
2021 (TTM)-NZ$0.13 Billion-5.33%
2020-NZ$0.14 Billion38.89%
2019-NZ$96.69 Million7.33%
2018-NZ$90.08 Million0.77%
2017-NZ$89.39 Million-67.64%
2016-NZ$0.28 Billion37.64%
2015-NZ$0.21 Billion176.1%
2014-NZ$72.69 Million-24.63%
2013-NZ$96.45 Million-43.51%
2012-NZ$0.18 Billion43.09%
2011-NZ$0.12 Billion190.88%
2010-NZ$41.02 Million102.46%
2009-NZ$20.26 Million-52.68%
2008-NZ$42.81 Million-10.33%
2007-NZ$47.75 Million15.35%
2006-NZ$41.39 Million355.36%
2005-NZ$9.09 Million13788.35%
2004-NZ$0.07 Million9.27%
2003-NZ$0.06 Million-10.26%
2002-NZ$0.07 Million-59.35%
2001-NZ$0.17 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
NZ$13.77 B-9,334.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-NZ$0.46 Billion 202.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$13.42 B-9,098.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Cleveland BioLabs
CBLI
-NZ$4.6 Million-96.92%๐Ÿ‡บ๐Ÿ‡ธ USA